- Report
- January 2026
- 185 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- August 2025
- 154 Pages
Global
From €2326EUR$2,650USD£2,013GBP
- Report
- June 2025
- 379 Pages
Global
From €4345EUR$4,950USD£3,760GBP
- Report
- June 2025
- 151 Pages
Global
From €3073EUR$3,500USD£2,658GBP
- Report
- February 2025
- 220 Pages
Global
From €5223EUR$5,950USD£4,519GBP
- Report
- May 2025
- 246 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- February 2026
- 177 Pages
Global
From €5136EUR$5,850USD£4,443GBP
- Report
- January 2026
- 186 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 182 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 193 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 192 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 190 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- January 2026
- 188 Pages
Global
From €3458EUR$3,939USD£2,992GBP
- Report
- October 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- April 2025
- 175 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- January 2026
- 182 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- August 2025
- 183 Pages
Global
From €3950EUR$4,500USD£3,418GBP
- Report
- April 2025
- 175 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- April 2025
- 250 Pages
Global
From €3942EUR$4,490USD£3,410GBP
- Report
- April 2025
- 200 Pages
Global
From €3942EUR$4,490USD£3,410GBP

The Automated Insulin Delivery (AID) market is a subset of the larger diabetes devices market. AID systems are designed to help people with diabetes manage their condition by automatically delivering insulin to the body. These systems are typically composed of an insulin pump, a continuous glucose monitor (CGM), and a control algorithm. The CGM measures glucose levels in the body and sends the data to the control algorithm, which then calculates the amount of insulin needed and sends a signal to the insulin pump to deliver the appropriate dose.
AID systems are designed to provide more accurate and consistent insulin delivery than traditional methods, and can help reduce the risk of hypoglycemia and other diabetes-related complications. They are also designed to be user-friendly and provide users with more control over their diabetes management.
Some companies in the AID market include Medtronic, Insulet, Tandem Diabetes Care, Bigfoot Biomedical, and Senseonics. Show Less Read more